InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Browse the full record of transactions filed by Tardio Jason. Director active across 2 companies, notably Ovid Therapeutics Inc.. Cumulatively, 4 filings have been published. Split: 2 buys · 1 sell. Total volume traded: €54k. Activity tracked since 12 September 2022. The latest transaction was filed on 5 June 2025 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Jason Tardio is a declarant associated with 4 filings in total. Across the 4 sampled recent filings, the reported buy amount is EUR 17260 and the reported sell amount is EUR 36813, covering the period from 2022-09-14 to 2025-06-20. He is listed as President and COO at Immunic, INC. and Chief Operating Officer at Ovid Therapeutics Inc.